Home › Eli Lilly to stop study of heart disease drug evacetrapib
 

Keywords :   


Eli Lilly to stop study of heart disease drug evacetrapib

2015-10-12 18:15:55| Biotech - Topix.net

Shares of Eli Lilly plunged Monday after the drugmaker said it would stop developing a heart disease treatment that had advanced deep into clinical testing. The Indianapolis company said researchers cited a lack of effectiveness, not safety concerns, in recommending an end to late-stage research on the drug, evacetrapib.

Tags: study stop heart drug

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.07Hurricane Beryl Graphics
05.07Hurricane Beryl Forecast Discussion Number 26
05.07Hurricane Beryl Wind Speed Probabilities Number 26
05.07Hurricane Beryl Forecast Advisory Number 26
05.07Hurricane Beryl Public Advisory Number 26
05.07Tropical Storm Aletta Graphics
05.07Tropical Storm Aletta Wind Speed Probabilities Number 3
05.07Summary for Tropical Storm Aletta (EP1/EP012024)
More »